109 related articles for article (PubMed ID: 7970444)
1. Usefulness of 99Tcm-N,N'-ethylene-1-dicysteine complex for dynamic kidney investigations.
Surma MJ; Wiewióra J; Liniecki J
Nucl Med Commun; 1994 Aug; 15(8):628-35. PubMed ID: 7970444
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of 99Tcm-bicisate as a renal imaging agent.
Ozker K; Kabasakal L; Liu Y; Hellman RS; Isitman A; Krasnow AZ; Collier BD
Nucl Med Commun; 1997 Aug; 18(8):771-5. PubMed ID: 9293508
[TBL] [Abstract][Full Text] [Related]
3. 99Tcm-cystine, a renal function and imaging agent: a comparative study in dog with 131I-hippurate and 99Tcm-glucoheptonate to evaluate its functional and imaging characteristics.
Misra M; Sarkar HS; Chakravarty M; Sanyal S; Ganguly S; Sarkar BR; Chatterjee J; Dobe P; Ghosh S; Banerjee S
Nucl Med Commun; 1994 Nov; 15(11):878-85. PubMed ID: 7870394
[TBL] [Abstract][Full Text] [Related]
4. Clearance and renal extraction of technetium-99m-L,L-ethylenedicysteine, I-131-ortho-iodohippurate and I-125-iothalamate in pigs.
Nielsen SS; Poulsen EU; Marqversen J; Nielsen LE; Bacher T; Rehling M
Clin Physiol; 1999 Jul; 19(4):338-43. PubMed ID: 10451795
[TBL] [Abstract][Full Text] [Related]
5. 99Tcm-N,N-ethylenedicysteine scintigraphy in children with various renal disorders: a comparative study with 99Tcm-MAG3.
Kibar M; Noyan A; Anarat A
Nucl Med Commun; 1997 Jan; 18(1):44-52. PubMed ID: 9061700
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic characteristics of 99mTc-Ethylene-l-dicysteine (99mTc-EC).
Surma MJ; Wiewiórka J; Szadkowska A; Liniecki J
Nucl Med Rev Cent East Eur; 1999; 2(1):20-7. PubMed ID: 14600996
[TBL] [Abstract][Full Text] [Related]
7. 99mTc-MAEC complexes: new renal radiopharmaceuticals combining characteristics of (99m)Tc-MAG3 and (99m)Tc-EC.
Taylor AT; Lipowska M; Hansen L; Malveaux E; Marzilli LG
J Nucl Med; 2004 May; 45(5):885-91. PubMed ID: 15136640
[TBL] [Abstract][Full Text] [Related]
8. Comparison of 99Tcm-mercaptoacetyltriglycine and 131I-orthoiodohippurate in determination of effective renal plasma flow (ERPF).
Abdel-Dayem HM; Sadek S; al-Bahar R; Sabha M; el-Sayed M
Nucl Med Commun; 1989 Feb; 10(2):99-107. PubMed ID: 2525236
[TBL] [Abstract][Full Text] [Related]
9. The use of 99Tcm-EC for captopril test in patients with hypertension.
Kostadinova I; Simeonova A
Nucl Med Commun; 1995 Mar; 16(3):128-31. PubMed ID: 7770233
[TBL] [Abstract][Full Text] [Related]
10. Parametric clearance kidney scintigrams; diagnostic potential in diabetes.
Frieske I; Surma MJ; Rogozińska-Zawiślak A; Szadkowska A; Gadzicki M; Bodalski J; Kuśmierek J
Nucl Med Rev Cent East Eur; 2007; 10(1):16-20. PubMed ID: 17694496
[TBL] [Abstract][Full Text] [Related]
11. Technetium-99m ethylene dicysteine: a new renal tubular function agent.
Kabasakal L
Eur J Nucl Med; 2000 Mar; 27(3):351-7. PubMed ID: 10774890
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of the kinetics of the renal tracers 99Tcm-MAG3 and 131I-hippuran.
Pavía J; Ros D; Piera C; Pavía A; Bassa P; Giralt E; Setoain J
Nucl Med Commun; 1991 Jun; 12(6):529-37. PubMed ID: 1830943
[TBL] [Abstract][Full Text] [Related]
13. Relationship between the OIH and 99Tcm-EC clearances.
Kabasakal L; Ozker K; Işitman AT; Onsel C
Nucl Med Commun; 1994 Dec; 15(12):1006-7. PubMed ID: 7715889
[No Abstract] [Full Text] [Related]
14. Evaluation of technetium-99m-L,L-EC in renal transplant recipients: a comparative study with technetium-99m-MAG3 and iodine-125-OIH.
Stoffel M; Jamar F; Van Nerom C; Verbruggen A; Mourad M; Leners N; Squifflet JP; Beckers C
J Nucl Med; 1994 Dec; 35(12):1951-8. PubMed ID: 7989976
[TBL] [Abstract][Full Text] [Related]
15. Iodine-131 Hippuran for the estimation of renal plasma flow: requirements for radiochemical purity.
Kengen RA; Meijer S; van Zanten AK; Beekhuis H; Kosterink JG; Albertus Piers D
Eur J Nucl Med; 1995 Jul; 22(7):678-81. PubMed ID: 7498230
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of renal scintigraphy with 99Tcm-mercaptoacetyltriglycine and 123I-orthoiodohippurate.
Itoh K; Tsukamoto E; Kakizaki H; Nonomura K; Furudate M
Nucl Med Commun; 1993 Aug; 14(8):644-52. PubMed ID: 8371889
[TBL] [Abstract][Full Text] [Related]
17. Technetium-99m-N,N-ethylenedicysteine--a comparative study of renal scintigraphy with technetium-99m-MAG3 and iodine-131-OIH in patients with obstructive renal disease.
Ozker K; Onsel C; Kabasakal L; Sayman HB; Uslu I; Bozluolçay S; Cansiz T; Kapicioğlu T; Urgancioğlu I
J Nucl Med; 1994 May; 35(5):840-5. PubMed ID: 8176468
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of technetium-99m-ethylenedicysteine in renal disorders and determination of extraction ratio.
Kabasakal L; Atay S; Vural VA; Ozker K; Sönmezoglu K; Demir M; Uslu I; Işitman AT; Onsel C
J Nucl Med; 1995 Aug; 36(8):1398-403. PubMed ID: 7629584
[TBL] [Abstract][Full Text] [Related]
19. Reproducibility of 99Tcm-MAG3 clearance in normal volunteers with the two-sample method: comparison with 131I-OIH.
Kanazawa T; Shimizu M; Seto H; Kageyama M; Kameda K; Toyoshima S; Tomizawa G; Watanabe N; Inagaki S
Nucl Med Commun; 1998 Sep; 19(9):899-903. PubMed ID: 10581597
[TBL] [Abstract][Full Text] [Related]
20. Comparison of technetium-99m MAG3 kit with HPLC-purified technetium-99m MAG3 and OIH in rats.
Coveney JR; Robbins MS
J Nucl Med; 1987 Dec; 28(12):1881-7. PubMed ID: 2960790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
